R. Shotton

Most-cited papers

1. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   Obbina Ali Fatima Mustafa Sadia Hakam Alfie Nabeel Ashraf Abani Abbas Abbas Abbas Abbasi Abbass Abbott Abdal, O. Abani, A. Abbas, F. Abbas +496 more

   2021The Lancet1,685 citations Open access

   Semantic Scholar

   Save

2. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   Eugenia Mustafa Sadia Alfie Ashraf Sherif Mohamed Basir Al Abaleke Abbas Abbasi Abbott Abdelaziz Abdelbadiee , E. Abaleke, M. Abbas, Sadia Abbasi +496 more

   2021The Lancet289 citations Open access

   Semantic Scholar

   Save

3. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

   Obbina Ali Fatima Mustafa Sadia Hakam Alfie Nabeel Ashraf Abani Abbas Abbas Abbas Abbasi Abbass Abbott Abdal, O. Abani, A. Abbas, F. Abbas +496 more

   2021The Lancet141 citations Open access

   Semantic Scholar

   Save

4. Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

   O. A. F. J. K. M. S. H. A. Abani Abbas Abbas Abbas Abbas Abbas Abbasi Abbass, O. Abani, A. Abbas, F. Abbas +496 more

   2023The Lancet103 citations Open access

   Semantic Scholar

   Save

5. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

   Obbina Ali Fatima Mustafa Sadia Hakam Alfie Nabeel Ashraf Abani Abbas Abbas Abbas Abbasi Abbass Abbott Abdal, O. Abani, A. Abbas, F. Abbas +496 more

   2022The Lancet45 citations Open access

   Semantic Scholar

   Save

6. Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort

   T. Bhogal, U. Khan, Rebecca Lee, A. Stockdale +19 more

   2021Leukemia and Lymphoma27 citations Open access

   Semantic Scholar

   Save

7. Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study

   A. Tivey, R. Shotton, T. Eyre, D. Lewis +64 more

   2023Blood Advances21 citations Open access

   Semantic Scholar

   Save

8. Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome

   R. Lee, Oskar Wysocki, T. Bhogal, R. Shotton +36 more

   2020ESMO Open19 citations Open access

   Semantic Scholar

   Save

9. A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications

   D. El-Sharkawi, A. Sud, Catherine Prodger, J. Khwaja +23 more

   2023Blood Cancer Journal14 citations Open access

   Semantic Scholar

   Save

10. Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review

    R. Shotton, A. Lamarca, J. Valle, M. McNamara

    2021World Journal of Gastrointestinal Oncology11 citations Open access

    Semantic Scholar

    Save

11. Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience

    R. Shotton, R. Broadbent, A. Alchawaf, M. Mohamed +22 more

    2023Blood Advances9 citations Open access

    Semantic Scholar

    Save

12. The impact of the COVID-19 pandemic upon pancreatic cancer treatment (CONTACT Study): a UK national observational cohort study

    L. Hall, S. Mckay, J. Halle-Smith, Joshua Soane +363 more

    2023British Journal of Cancer7 citations Open access

    Semantic Scholar

    Save

13. Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital

    R. Lee, Oskar Wysocki, Cong Zhou, R. Shotton +73 more

    2022JCO Clinical Cancer Informatics6 citations Open access

    Semantic Scholar

    Save

14. Real-world outcomes of immune-related adverse events in 2,125 patients managed with immunotherapy: A United Kingdom multicenter series.

    A. Olsson-Brown, M. Baxter, C. Dobeson, L. Feeney +11 more

    20206 citations

    Semantic Scholar

    Save

15. Patient engagement in melanoma research: from bench to bedside.

    A. Tivey, P. Huddar, R. Shotton, Imogen Cheese +3 more

    2021Future Oncology5 citations

    Semantic Scholar

    Save

16. Real-world outcomes in older adults treated with immunotherapy: A United Kingdom multicenter series of 2,049 patients.

    A. Olsson-Brown, M. Baxter, C. Dobeson, L. Feeney +16 more

    20215 citations Open access

    Semantic Scholar

    Save

17. REAL WORLD OUTCOMES AND RESPONSES TO SECOND‐LINE THERAPY IN RELAPSED/REFRACTORY HODGKIN LYMPHOMA: A MULTICENTRE UK STUDY

    R. Shotton, Amy A. Kirkwood, M. Northend, D. Fathoal +18 more

    2021Hematological Oncology3 citations Open access

    Semantic Scholar

    Save

18. P130. Negative pressure wound therapy (NPWT) on complex closed breast incisions promotes wound healing

    R. Holt, R. Shotton, J. Murphy

    20153 citations

    Semantic Scholar

    Save

19. An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves

    Oskar Wysocki, Cong Zhou, J. Rogado, P. Huddar +70 more

    2022Cancers2 citations Open access

    Semantic Scholar

    Save

20. 743P Real-world outcomes in patients treated with trametinib for low grade serous ovarian carcinoma

    R. Shotton, X. Ren, M. Randhawa, M. Tilby +8 more

    2021Annals of Oncology2 citations Open access

    Semantic Scholar

    Save

21. P1141: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: A MULTICENTRE, REAL-WORLD UK STUDY

    A. Tivey, R. Shotton, T. Eyre, D. Lewis +37 more

    2022HemaSphere1 citations Open access

    Semantic Scholar

    Save

22. The association of pre-existing autoimmune disease and immune-related adverse events secondary to immune checkpoint inhibition therapy in a UK multicenter cohort.

    A. Olsson-Brown, M. Baxter, L. Feeney, A. Tivey +16 more

    2022Journal of Clinical Oncology1 citations

    Semantic Scholar

    Save

23. 1722P Longitudinal analysis of biochemical and haematological features of cancer patients with COVID-19

    A. Tivey, R. Shotton, R. Lee, Cong Zhou +6 more

    2020Annals of Oncology1 citations Open access

    Semantic Scholar

    Save

24. Audit of systemic therapies for older patients with lung cancer in a DGH setting

    R. Shotton, D. Patterson

    20181 citations

    Semantic Scholar

    Save

25. Treatment and outcomes of immunotherapy related colitis and hepatitis- a multi-centre cohort study in the United Kingdom by the National Oncology Trainee Collaborative for Healthcare Research (NOTCH)

    Mirashini Swaminathan, A. Angelakas, M. Baxter, J. Cotton +17 more

    2026Supportive Care in Cancer0 citations Open access

    Semantic Scholar

    Save

26. SWATH-MS for discovery of early biomarkers of drug-induced cardiotoxicity using an animal doxorubicin model

    R. Shotton, Amy Campbell, I. Baricevic-Jones, Rachel Reed +5 more

    2026Cardio-Oncology0 citations Open access

    Semantic Scholar

    Save

27. 52P Clinical outcomes of relapsed or refractory classical Hodgkin lymphoma, including those unsuitable or refractory to stem cell transplant

    M. Giles, R. Shotton, B. Phillips, K. Linton

    2025ESMO Open0 citations Open access

    Semantic Scholar

    Save

28. DIGITAL ANALYSIS OF ACOUSTIC DATA FROM HERRING SCHOOLS

    R. Shotton, U. Buerkle

    2024Acoustics in Fisheries 19780 citations Open access

    Semantic Scholar

    Save

29. P1102: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: UPDATED OUTCOMES FROM A MULTICENTRE, REAL-WORLD UK STUDY

    R. Shotton, A. Tivey, T. Eyre, D. Lewis +22 more

    2023HemaSphere0 citations Open access

    Semantic Scholar

    Save

30. Bendamustine Plus Brentuximab Has Superior Efficacy to Brentuximab Monotherapy As Third-Line Treatment for Classical Hodgkin Lymphoma: A Real-World, Multicentre UK Analysis

    R. Shotton, A. Kirkwood, M. Northend, Dina Fathoala +18 more

    2023Blood0 citations Open access

    Semantic Scholar

    Save

31. 241P Treatment and outcomes of patients with gastrointestinal toxicity following immunotherapy: A large multi-center retrospective study in the United Kingdom by the National Oncology Trainees Collaborative for Healthcare Research (NOTCH)

    M. Swaminathan, A. Angelakas, M. Baxter, J. Cotton +16 more

    2022Immuno-Oncology and Technology0 citations Open access

    Semantic Scholar

    Save

32. Outlier detection of vital sign trajectories from COVID-19 patients

    Sara Summerton, A. Tivey, R. Shotton, Gavin Brown +4 more

    2022Annual International Conference of the IEEE Engineering in Medicine and Biology Society0 citations Open access

    Semantic Scholar

    Save

33. Establishment of CORONET: COVID-19 Risk in Oncology Evaluation Tool to Identify Cancer Patients at Low Versus High Risk of Severe Complications of COVID-19 Infection Upon Presentation to Hospital

    Rebecca Lee, Oskar Wysocki, Cong Zhou, R. Shotton +64 more

    2021Social Science Research Network0 citations Open access

    Semantic Scholar

    Save

34. Erratum to ‘Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome’

    R. Lee, Oskar Wysocki, T. Bhogal, R. Shotton +36 more

    2021ESMO Open0 citations Open access

    Semantic Scholar

    Save

35. Selection, Administration and Description of Neoadjuvant versus Adjuvant Therapy for Upper Tract Urothelial Carcinoma

    R. Shotton, A. Birtle

    2021Bladder Cancer0 citations

    Semantic Scholar

    Save

36. Preoperative low skeletal muscle mass was not related to postoperative complications or length of hospital stay in patients with colorectal cancer

    C. Atkinson, S. Burden, J. Sremanakova, R. Shotton +5 more

    20200 citations

    Semantic Scholar

    Save

37. 1690P Development of a model to predict hospital admission and severe outcome in cancer patients with COVID-19

    R. Lee, Cong Zhou, R. Shotton, A. Tivey +16 more

    2020Annals of Oncology0 citations Open access

    Semantic Scholar

    Save

38. East Anglian audit of pembrolizumab in non-small cell lung cancer

    A. Jackson, R. Fenn, R. Shotton, A. Williams +5 more

    20180 citations

    Semantic Scholar

    Save

39. Reference ranges for salivary steroid measurement during short synacthen tests

    R. Shotton, I. Perogamvros, B. Keevil, P. Monaghan +2 more

    20140 citations

    Semantic Scholar

    Save